EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Perspective: Multiomics and Artificial Intelligence for Personalized Nutritional Management of Diabetes in Patients Undergoing Peritoneal Dialysis

Sara Mahdavi, Nicole M Anthony, Tabo Sikaneta, Paul Y Tam

Advances in Nutrition · 2025-03 · 16 (3) · 100378

DOI: 10.1016/j.advnut.2025.100378 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Nutrition, 2025-03. Verfasst von Sara Mahdavi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, United States; Department of Nutritional Sciences, University of Tor…. Hauptthemen laut MEDLINE: Artificial Intelligence, Peritoneal Dialysis, Precision Medicine, Diabetes Mellitus. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Managing diabetes in patients on peritoneal dialysis (PD) is challenging due to the combined effects of dietary glucose, glucose from dialysate, and other medical complications. Advances in technology that enable continuous biological data collection are transforming traditional management approaches. This review explores how multiomics technologies and artificial intelligence (AI) are enhancing glucose management in this patient population. Continuous glucose monitoring (CGM) offers significant advantages over traditional markers, such as hemoglobin A1c (HbA1c). Unlike HbA1c, which reflects an mean glucose level, CGM provides real-time, dynamic glucose data that allow clinicians to make timely adjustments, leading to better glycemic control and outcomes. Multiomics approaches are valuable for understanding genetic factors that influence susceptibility to diabetic complications, particularly those related to advanced glycation end products (AGEs). Identifying genetic polymorphisms that modify a patient's response to AGEs allows for personalized treatments, potentially reducing the severity of diabetes-related pathologies. Metabolomic analyses of PD effluent are also promising, as they help identify early biomarkers of metabolic dysregulation. Early detection can lead to timely interventions and more tailored treatment strategies, improving long-term patient care. AI integration is revolutionizing diabetes management for PD patients by processing vast datasets from CGM, genetic, metabolic, and microbiome profiles. AI can identify patterns and predict outcomes that may be difficult for humans to detect, enabling highly personalized recommendations for diet, medication, and dialysis management. Furthermore, AI can assist clinicians by automating data interpretation, improving treatment plans, and enhancing patient education. Despite the promise of these technologies, there are limitations. CGM, multiomics, and AI require significant investment in infrastructure, training, and validation studies. Additionally, integrating these approaches into clinical practice presents logistical and financial challenges. Nevertheless, personalized, data-driven strategies offer great potential for improving outcomes in diabetes management for PD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligencePeritoneal DialysisPrecision MedicineDiabetes MellitusHumansBlood GlucoseGlycation End Products, AdvancedMetabolomicsGlycated HemoglobinBiomarkersMultiomics

Stichwörter der Autor:innen

artificial intelligencediabeteskidney diseaseomicsperitoneal dialysisprecision nutrition

Substanzen

Blood GlucoseGlycation End Products, AdvancedGlycated HemoglobinBiomarkers

Autor:innen und Institutionen

  • Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, United States; Department of Nutritional Sciences, University of Toronto, 6 Queen's Park Cres, Toronto, Ontario, Canada; Department of Nep…
  • Department of Nutritional Sciences, University of Toronto, 6 Queen's Park Cres, Toronto, Ontario, Canada.
  • Department of Nephrology, the Scarborough Health Network, Toronto, Ontario, Canada.
  • Department of Nephrology, the Scarborough Health Network, Toronto, Ontario, Canada; Kidney Life Sciences Institute, Toronto, Ontario, Canada.

Zitieren

APA

Mahdavi, S., Anthony, N. M., Sikaneta, T., & Tam, P. Y. (2025). Perspective: Multiomics and Artificial Intelligence for Personalized Nutritional Management of Diabetes in Patients Undergoing Peritoneal Dialysis. Advances in Nutrition, 16(3), 100378. https://doi.org/10.1016/j.advnut.2025.100378

Vancouver

Mahdavi S, Anthony NM, Sikaneta T, Tam PY. Perspective: Multiomics and Artificial Intelligence for Personalized Nutritional Management of Diabetes in Patients Undergoing Peritoneal Dialysis. Advances in Nutrition. 2025;16(3):100378. doi:10.1016/j.advnut.2025.100378

BibTeX
@article{Mahdavi2025,
  author = {Mahdavi, Sara and Anthony, Nicole M and Sikaneta, Tabo and Tam, Paul Y},
  title = {Perspective: Multiomics and Artificial Intelligence for Personalized Nutritional Management of Diabetes in Patients Undergoing Peritoneal Dialysis},
  journal = {Advances in Nutrition},
  year = {2025},
  volume = {16},
  number = {3},
  pages = {100378},
  doi = {10.1016/j.advnut.2025.100378}
}
Kostenlos starten →